Cargando…
Synthesis, characterization, and cytotoxicity of doxorubicin-loaded polycaprolactone nanocapsules as controlled anti-hepatocellular carcinoma drug release system
BACKGROUND: Free doxorubicin (Dox) is used as a chemotherapeutic agent against hepatocellular carcinoma (HCC), but it results in cardiotoxicty as a major side effect. Hence, a controlled Dox drug delivery system is extremely demanded. METHODS: Dox was loaded into the non-toxic biodegradable polycapr...
Autores principales: | Fahmi, Abdelgawad, Abdur-Rahman, Mariam, Mahareek, Omnia, shemis, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655909/ https://www.ncbi.nlm.nih.gov/pubmed/36371274 http://dx.doi.org/10.1186/s13065-022-00888-w |
Ejemplares similares
-
Biological evaluation of protein nanocapsules containing doxorubicin
por: Toita, Riki, et al.
Publicado: (2013) -
In Vitro Cytotoxicity and In Vivo Antitumor Activity of Lipid Nanocapsules Loaded with Novel Pyridine Derivatives
por: Abu Lila, Amr Selim, et al.
Publicado: (2023) -
Phosphorylcholine-based stealthy nanocapsules enabling tumor microenvironment-responsive doxorubicin release for tumor suppression
por: Liu, Gan, et al.
Publicado: (2017) -
Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells
por: Pinzón-García, Ana D., et al.
Publicado: (2021) -
Phenylboronic Acid-Grafted Chitosan Nanocapsules for Effective Delivery and Controllable Release of Natural Antioxidants: Olive Oil and Hydroxytyrosol
por: Hendawy, Omnia M., et al.
Publicado: (2022)